Is a complete HROW research report available?

No complete published report is available for Harrow, Inc. (HROW) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Harrow, Inc. (HROW)

NASDAQ: HROW · USD

$29.4

+0.32 (+1.1%)· Recorded snapshot

Market cap	1.1B
Revenue (ttm)	275.6M
Net income (ttm)	-37.2M
EPS (ttm)	-$1.00
Shares out	37.5M
P/E (forward)	23.0x
Volume	257,912
Beta	0.18

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 275.6M
Net income (ttm): -37.2M
EPS (ttm): -$1.00
P/E (forward): 23.0x
Market cap: 1.1B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	होल्ड

Metric	Value
Amount currency	USD
CIK code	0001360214
Company name	Harrow, Inc.
Country	United States
Country code	US
CUSIP number	415858109
Earnings date	2026-11-09
Earnings time	amc
Employees	373
Employees change	-9
Employees growth	-2.36%
Enterprise value	$1.3B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1998
In index	RUSSELL2000
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
Is SPAC	No
ISIN number	US4158581094
Last 10-K release date	2026-03-02
Last earnings date	2026-08-10
Last refreshed	2026-10-28
Last stock split date	2013-02-08
Last stock split type	Reverse
Market cap	$1.1B
Market cap category	Small-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$29.39
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	HROW
U.S. state	Tennessee
Website	https://www.harrow.com

Metric

Value

Amount currency

USD

CIK code

0001360214

Company name

Harrow, Inc.

Country

United States

Country code

CUSIP number

415858109

Earnings date

2026-11-09

Earnings time

amc

Employees

373

Employees change

-9

Employees growth

-2.36%

Enterprise value

$1.3B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1998

In index

RUSSELL2000

Industry

Drug Manufacturers - Specialty & Generic

Is primary listing

Yes

Is SPAC

ISIN number

US4158581094

Last 10-K release date

2026-03-02

Last earnings date

2026-08-10

Last refreshed

2026-10-28

Last stock split date

2013-02-08

Last stock split type

Reverse

Market cap

$1.1B

Market cap category

Small-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$29.39

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

HROW

U.S. state

Tennessee

Website

https://www.harrow.com

Metric	Value
Earnings yield	-3.4%
EV/EBITDA	74.48x
EV/FCF	263.05x
EV/Sales	4.79x
FCF / EV yield	0.38%
FCF yield	0.45%
Forward EV/Sales	2.96x
Forward P/E	23.04x
Forward P/S	2.47x
Industry forward P/E	13.86x
Industry P/E	173.47x
P/B ratio	71.69x
P/FCF ratio	220.1x
P/OCF ratio	176.59x
P/S ratio	4.01x
Price/EBITDA ratio	62.32x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-3.4%

EV/EBITDA

74.48x

EV/FCF

263.05x

EV/Sales

4.79x

FCF / EV yield

0.38%

FCF yield

0.45%

Forward EV/Sales

2.96x

Forward P/E

23.04x

Forward P/S

2.47x

Industry forward P/E

13.86x

Industry P/E

173.47x

P/B ratio

71.69x

P/FCF ratio

220.1x

P/OCF ratio

176.59x

P/S ratio

4.01x

Price/EBITDA ratio

62.32x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	-1%
EBITDA margin	6.43%
FCF margin	1.82%
Gross margin	73.28%
Operating margin	-1%
Pretax margin	-12.13%
Profit margin	-13.51%
Profit per employee	$-99,802
Revenue per employee	$738,858
ROA	-0.45%
ROA (5Y)	2.06%
ROCE	-0.87%
ROE	-116.07%
ROE (5Y)	-50.53%
ROIC	-1.19%
SBC / revenue	5.33%
Tax / revenue	1.38%

Metric

Value

EBIT margin

-1%

EBITDA margin

6.43%

FCF margin

1.82%

Gross margin

73.28%

Operating margin

-1%

Pretax margin

-12.13%

Profit margin

-13.51%

Profit per employee

$-99,802

Revenue per employee

$738,858

ROA

-0.45%

ROA (5Y)

2.06%

ROCE

-0.87%

ROE

-116.07%

ROE (5Y)

-50.53%

ROIC

-1.19%

SBC / revenue

5.33%

Tax / revenue

1.38%

Metric	Value
EPS growth years	2
FCF growth	97.33%
FCF growth 5Y	-11.16%
Gross profit growth	18.97%
Gross profit growth (Q)	6%
Gross profit growth 3Y	41.31%
Gross profit growth 5Y	34%
Net income growth years	2
OCF growth	54.87%
OCF growth 5Y	-10.27%
Revenue growth	21.06%
Revenue growth (Q)	10.86%
Revenue growth (QoQ)	59.86%
Revenue growth 10Y	33.37%
Revenue growth 3Y	38.95%
Revenue growth 5Y	34.52%
Revenue growth quarters	1
Revenue growth years	5

Metric

Value

EPS growth years

FCF growth

97.33%

FCF growth 5Y

-11.16%

Gross profit growth

18.97%

Gross profit growth (Q)

Gross profit growth 3Y

41.31%

Gross profit growth 5Y

34%

Net income growth years

OCF growth

54.87%

OCF growth 5Y

-10.27%

Revenue growth

21.06%

Revenue growth (Q)

10.86%

Revenue growth (QoQ)

59.86%

Revenue growth 10Y

33.37%

Revenue growth 3Y

38.95%

Revenue growth 5Y

34.52%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-1.2M
Depreciation and amortization	$20.5M
EBIT	$-2.7M
EBITDA	$17.7M
EPS	$-1.00
FCF per share	$0.13
Financing cash flow	$48.4M
Free cash flow	$5M
Free cash flow minus SBC	$-9.7M
Gross profit	$202M
Income taxes	$3.8M
Investing cash flow	$-23.7M
Net borrowing	$62.5M
Net cash flow	$30.9M
Net income	$-37.2M
Operating cash flow minus SBC	$-8.4M
Operating income	$-2.7M
Revenue	$275.6M
Stock-based compensation	$14.7M

Metric

Value

Capital expenditures

$-1.2M

Depreciation and amortization

$20.5M

EBIT

$-2.7M

EBITDA

$17.7M

EPS

$-1.00

FCF per share

$0.13

Financing cash flow

$48.4M

Free cash flow

$5M

Free cash flow minus SBC

$-9.7M

Gross profit

$202M

Income taxes

$3.8M

Investing cash flow

$-23.7M

Net borrowing

$62.5M

Net cash flow

$30.9M

Net income

$-37.2M

Operating cash flow minus SBC

$-8.4M

Operating income

$-2.7M

Revenue

$275.6M

Stock-based compensation

$14.7M

Metric	Value
Altman Z-Score	2.55
Book value per share	$0.41
Debt / EBITDA	15.7
Debt / equity	20.26
Debt / FCF	59.96
Goodwill	$332,000
Interest coverage	-0.12
Long-term assets	$187.5M
Long-term liabilities	$299.8M
Net cash (debt)	$-215.4M
Net cash / market cap	-19.51%
Net debt / EBITDA	12.16
Net debt / equity	14.51
Net debt / FCF	42.95
Piotroski F-Score	4
Property, plant and equipment	$10.4M
Shareholders' equity	$14.8M
Tangible book value	$-162M
Tangible book value per share	$-4.32
Total assets	$416.8M
Total cash	$85.3M
Total debt	$300.7M
Total liabilities	$402M
WACC	5.43%

Metric

Value

Altman Z-Score

2.55

Book value per share

$0.41

Debt / EBITDA

15.7

Debt / equity

20.26

Debt / FCF

59.96

Goodwill

$332,000

Interest coverage

-0.12

Long-term assets

$187.5M

Long-term liabilities

$299.8M

Net cash (debt)

$-215.4M

Net cash / market cap

-19.51%

Net debt / EBITDA

12.16

Net debt / equity

14.51

Net debt / FCF

42.95

Piotroski F-Score

Property, plant and equipment

$10.4M

Shareholders' equity

$14.8M

Tangible book value

$-162M

Tangible book value per share

$-4.32

Total assets

$416.8M

Total cash

$85.3M

Total debt

$300.7M

Total liabilities

$402M

WACC

5.43%

Metric	Value
Asset turnover	0.72
Current assets	$229.3M
Current liabilities	$102.2M
Current ratio	2.24
Inventory turnover	5.17
Net working capital	$42.8M
Quick ratio	2
Working capital	$127.1M
Working capital turnover	16.63

Metric

Value

Asset turnover

0.72

Current assets

$229.3M

Current liabilities

$102.2M

Current ratio

2.24

Inventory turnover

5.17

Net working capital

$42.8M

Quick ratio

Working capital

$127.1M

Working capital turnover

16.63

Metric	Value
Buyback yield / dilution	-3.39%
Dividend yield	0%
Shareholder yield	-3.39%

Metric

Value

Buyback yield / dilution

-3.39%

Dividend yield

Shareholder yield

-3.39%

Metric	Value
10Y price change	975%
10Y return CAGR	26.81%
10Y total return	975%
150-day SMA	$36.79
15Y price change	915.28%
15Y return CAGR	16.71%
15Y total return	915.28%
1D price change	1.1%
1M price change	-11.58%
1M total return	-11.58%
1W price change	4.17%
1W total return	4.17%
1Y price change	-23.54%
1Y return CAGR	-23.55%
1Y total return	-23.54%
20-day SMA	$29.05
200-day SMA	$38.53
3M price change	-21.94%
3M total return	-21.94%
3Y price change	113.28%
3Y return CAGR	28.71%
3Y total return	113.28%
50-day SMA	$33.37
50-day SMA vs 200-day SMA	50under200
52-week high	$54.85
52-week high date	2026-01-07
52-week low	$26.96
52-week low date	2026-10-14
5Y price change	206.18%
5Y return CAGR	25.09%
5Y total return	206.18%
6M price change	-29.39%
6M total return	-29.39%
All-time high	$160.00
All-time high date	2009-10-06
All-time low	$0.50
All-time low date	2012-03-16
Average true range (ATR)	$1.33
Average volume	611K
Beta (1Y)	2.12
Beta (2Y)	2.1
Beta (5Y)	0.18
Change from 52-week high	-46.42%
Change from 52-week low	9.01%
Change from all-time high	-81.73%
Change from all-time low	5,748%
Change from open	0.48%
Day's gap	0.62%
Dollar volume	$7.6M
High price	$29.59
Low price	$29.09
Monthly RSI	46.48
Open price	$29.25
Position in 52-week range	60%
Premarket change	0.34%
Premarket close	$29.07
Premarket price	$29.17
Premarket volume	457
Previous close	$29.07
Price vs 150-day SMA	-20.51%
Price vs 20-day SMA	0.66%
Price vs 200-day SMA	-24.12%
Price vs 50-day SMA	-12.37%
Relative volume	0.42
RSI	42.61
Sharpe ratio	-0.16
Sharpe ratio (3Y)	0.63
Sharpe ratio (5Y)	0.59
Sortino ratio	-0.13
Sortino ratio (3Y)	1.09
Sortino ratio (5Y)	1.04
Volume	257.9K
Weekly RSI	39.37
YTD price change	-40.33%
YTD total return	-40.33%

Metric

Value

10Y price change

975%

10Y return CAGR

26.81%

10Y total return

975%

150-day SMA

$36.79

15Y price change

915.28%

15Y return CAGR

16.71%

15Y total return

915.28%

1D price change

1.1%

1M price change

-11.58%

1M total return

-11.58%

1W price change

4.17%

1W total return

4.17%

1Y price change

-23.54%

1Y return CAGR

-23.55%

1Y total return

-23.54%

20-day SMA

$29.05

200-day SMA

$38.53

3M price change

-21.94%

3M total return

-21.94%

3Y price change

113.28%

3Y return CAGR

28.71%

3Y total return

113.28%

50-day SMA

$33.37

50-day SMA vs 200-day SMA

50under200

52-week high

$54.85

52-week high date

2026-01-07

52-week low

$26.96

52-week low date

2026-10-14

5Y price change

206.18%

5Y return CAGR

25.09%

5Y total return

206.18%

6M price change

-29.39%

6M total return

-29.39%

All-time high

$160.00

All-time high date

2009-10-06

All-time low

$0.50

All-time low date

2012-03-16

Average true range (ATR)

$1.33

Average volume

611K

Beta (1Y)

2.12

Beta (2Y)

2.1

Beta (5Y)

0.18

Change from 52-week high

-46.42%

Change from 52-week low

9.01%

Change from all-time high

-81.73%

Change from all-time low

5,748%

Change from open

0.48%

Day's gap

0.62%

Dollar volume

$7.6M

High price

$29.59

Low price

$29.09

Monthly RSI

46.48

Open price

$29.25

Position in 52-week range

60%

Premarket change

0.34%

Premarket close

$29.07

Premarket price

$29.17

Premarket volume

457

Previous close

$29.07

Price vs 150-day SMA

-20.51%

Price vs 20-day SMA

0.66%

Price vs 200-day SMA

-24.12%

Price vs 50-day SMA

-12.37%

Relative volume

0.42

RSI

42.61

Sharpe ratio

-0.16

Sharpe ratio (3Y)

0.63

Sharpe ratio (5Y)

0.59

Sortino ratio

-0.13

Sortino ratio (3Y)

1.09

Sortino ratio (5Y)

1.04

Volume

257.9K

Weekly RSI

39.37

YTD price change

-40.33%

YTD total return

-40.33%

Metric	Value
Float	28.9M
Float percentage	77.17%
Shares change (QoQ)	0.32%
Shares change (YoY)	3.39%
Shares held by insiders	16.43%
Shares held by institutions	52.92%
Shares outstanding	37.5M
Short % of float	25.84%
Short % of shares	19.94%
Short ratio	14 days

Metric

Value

Float

28.9M

Float percentage

77.17%

Shares change (QoQ)

0.32%

Shares change (YoY)

3.39%

Shares held by insiders

16.43%

Shares held by institutions

52.92%

Shares outstanding

37.5M

Short % of float

25.84%

Short % of shares

19.94%

Short ratio

14 days

Harrow, Inc. (HROW)

Price

Financial snapshot

Fair-value bridge

Latest news · HROW

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All HROW indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on HROW

Frequently asked questions